It's a landmark ruling in the world of global medicine that could have far-reaching implications. A Swiss drug manufacturer has lost a battle in India to patent an updated version of its cancer medication.
FOX News Radio's Emily Wither reports:
The ruling is a serious blow to Western pharmaceutical firms.
(Court Spokeswoman) "The Supreme Court judgment today, Novartis case, is that Novartis's appeal has been dismissed."
The Swiss drugs firm Novartis was denied a patent of its cancer drugs because Indian authorities said the new version is only slightly different to the old. The decision means drug makers can continue selling copies at a lower price.
Many aid organizations welcome the ruling, as it means poor patients can continue to access cheap versions of life-saving medicines. The company, however, say it will discourage medical progress in the country.
Emily Wither, FOX News Radio.